We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RSLS market cap is 3.99M. The company's latest EPS is USD -0.4854 and P/E is -0.35.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.8M | 3.11M | 2.29M | 2.25M | 2.16M |
| Operating Income | -11.93M | -16.5M | -5.63M | -4.01M | -3.88M |
| Net Income | -11.81M | -16.61M | -2.66M | -3.49M | -3.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.28M | 1.59M | 13.6M | 11.24M | 8.68M |
| Operating Income | -23.23M | -10.64M | -27.75M | -45.82M | -15.42M |
| Net Income | -23.68M | -12.33M | -61.93M | -46.21M | -11.39M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.46M | 11.14M | 16.35M | 11.85M | 7.83M |
| Total Liabilities | 7.51M | 7.48M | 8.59M | 5.11M | 4.74M |
| Total Equity | 20.94M | 3.66M | 7.76M | 6.74M | 3.08M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 20.39M | 10.62M | 54.26M | 11.14M | 10.66M |
| Total Liabilities | 4.54M | 5.95M | 8.19M | 7.48M | 4M |
| Total Equity | 15.85M | 4.67M | 46.07M | 3.66M | 6.66M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.07M | -21.9M | -5.06M | -11.72M | -14.5M |
| Investing | -13k | -92k | -7k | -10k | -10k |
| Financing | 2.49M | 3.13M | 10.2M | 12.45M | 12.11M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.87M | -10.41M | -15.38M | -21.9M | -16.96M |
| Investing | 2.36M | -171k | 1.86M | -92k | -10k |
| Financing | 13.38M | 430k | 33.3M | 3.13M | 17.57M |
| Market Cap | 3.99M |
| Price to Earnings Ratio | -0.35 |
| Price to Sales Ratio | 0.46 |
| Price to Cash Ratio | 0.89 |
| Price to Book Ratio | 0.6 |
| Dividend Yield | - |
| Shares Outstanding | 23.46M |
| Average Volume (1 week) | 212.54k |
| Average Volume (1 Month) | 197.73k |
| 52 Week Change | -93.63% |
| 52 Week High | 2.798 |
| 52 Week Low | 0.1414 |
| Spread (Intraday) | 0 (2.47%) |
| Company Name | ReShape Lifesciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.reshapelifesciences.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
